Cancer BiologybioRxivPreprint
USP18 Inhibition Enhances Type I Interferon Signalling and Immune Activation in the Tumour Microenvironment of Triple-Negative Breast Cancer
Chartinun Chutoe, Emily R. Webb, Morwenna Muir…·Alex von Kriegsheim
This study shows that inhibiting USP18 enhances type I interferon signaling and immune activation in TNBC, converting immunologically cold tumors into hot ones and improving immunotherapy efficacy.
DOI 10.1101/2025.09.01.672152